Screener
Biogen BIIB EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income tax (benefit) expense | 34.9 | 109.2 | 93.1 | 179.9 |
| Net income attributable to Biogen Inc. | $97.5 | $634.8 | $417.0 | $875.3 |
| Net income per share: | ||||
| Basic earnings per share attributable to Biogen Inc. | $0.66 | $4.33 | $2.83 | $5.98 |
| Diluted earnings per share attributable to Biogen Inc. | $0.66 | $4.33 | $2.81 | $5.97 |
| Weighted-average shares used in calculating: | ||||
| Basic earnings per share attributable to Biogen Inc. | 147.7 | 146.5 | 147.4 | 146.3 |
| Diluted earnings per share attributable to Biogen Inc. | 148.7 | 146.7 | 148.6 | 146.7 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's EPS (basic)?
- Biogen (BIIB) reported EPS (basic) of $0.66 in Q2 2026.
- How has Biogen's EPS (basic) changed year-over-year?
- Biogen's EPS (basic) decreased by 84.8% year-over-year, from $4.33 to $0.66.
- What is the long-term trend for Biogen's EPS (basic)?
- Over 4 years (2021 to 2025), Biogen's EPS (basic) has grown at a -3.2% compound annual growth rate (CAGR), from $10.43 to $9.16.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Biogen's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude